Cognitive Testing Battery: differences among groups with dementia, Huntington's disease, and controls.
This study evaluated a new test for dementia, the Cognitive Testing Battery, used for over six years in outpatient clinics for aging-related disorders. This battery was developed to be brief, easy to administer, and to provide useful feedback as a cognitive profile for clinicians, patients, and caregivers. 489 participants were tested during a 5-yr. period. Multidisicplinary teams diagnosed these patients with dementia, depression, or Huntington's Disease. A control group was also included. Groups were then compared on the 10 key subscales that subserve dementia populations. Analysis showed there were significant differences among the groups on all measures and that selected scales differentiated the groups. The total score maximally differentiated the groups, and the dementia group was most different from the other groups.
Hyer
Lee
L
University of Medicine and Dentistry of New Jersey, USA. hyerla@cmhc.umdnj.edu
Sohnle
Steven
S
Miller
Michael H
MH
Hamer
Robert
R
D000368:Aged; D000375:Aging; D003072:Cognition Disorders / Q000175:diagnosis* / Q000453:epidemiology; D003704:Dementia / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000453:epidemiology*; D008297:Male; D009483:Neuropsychological Tests; D012720:Severity of Illness Index